术中转开胸不影响微创食管切除术治疗食管癌的肿瘤学结局
研究回顾293例胸段食管鳞癌患者中257例接受胸腔镜食管切除术者,比较完全微创与中转开胸两组的围术期变量及长期生存。结果显示中转率10.1%,中转组手术时间更长、出血更多,但单因素和多因素分析均表明术中转开胸未显著影响总生存和无复发生存。
要点
- 中转开胸率为10.1%(26/257),多数发生在最初100例。
- 中转组手术时间显著更长、术中出血更多。
- 中转开胸未显著影响总生存和无复发生存。
核心结论
- 术中转开胸不影响接受微创食管切除术的食管鳞癌患者的长期生存。
研究设计与样本
- 回顾性队列研究,纳入2009年9月至2015年8月由作者实施的257例胸段食管鳞癌胸腔镜食管切除术患者,分为完全微创组和中转开胸组进行比较。
主要发现
- 231例(89.9%)成功完成胸腔镜食管切除术,26例(10.1%)中转开胸。
- 中转开胸多数(73.1%,19/26)发生在最初100例中。
- 两组背景和临床病理因素无显著差异,但中转组手术时间显著更长、术中出血更多。
- 26例中转患者中9例因各种原因需紧急中转,最常见原因为术中出血。
- 单因素和多因素分析均表明术中中转未显著影响总生存和无复发生存。
临床怎么用
- 微创食管切除术中因出血等原因中转开胸不应被视为肿瘤学失败,应基于术中情况果断决策。
局限性
- 回顾性单中心研究,样本量有限,中转组仅26例,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to summarize the causes and implications of intraoperative conversion from minimally invasive esophagectomy (MIE) to open thoracotomy, and to evaluate the effect on long-term survival. METHODS: There were 293 thoracoscopic esophagectomies for esophageal squamous cell carcinoma (ESCC) of the thoracic esophagus performed by the authors from September 2009 to August 2015. Totally, 257 patients were enrolled in this study. These patients were divided into two groups (those underwent complete MIE and those converted to open thoracotomy) and then compared. A standardized preoperative evaluation, as well as a postoperative method of following at a regular frequency were adopted for all of these patients. The clinicopathologic characteristics and the perioperative variables were retrospectively analyzed. Univariate and multivariate analyses were performed to identify prognostic factors. And the Kaplan-Meier method was used to compare survival differences. RESULTS: There were 231 patients (89.9%) underwent successful thoracoscopic esophagectomy (Group 1), and 26 cases (10.1%) required conversion to open procedure (Group 2). The majority of conversion (73.1%, 19/26) occurred in the initial 100 cases. No significant difference in background or clinicopathologic factors between the two groups was observed, but patients in Group 2 had significantly longer operative time and more operative blood loss. Among the 26 patients of Group 2, there were nine cases that need emergent conversion for various reasons. And the most common cause for emergent conversion was intraoperative bleeding. Univariate and multivariate analyses all demonstrated that intraoperative conversion did not significantly influence the overall or recurrence-free survival of these patients. CONCLUSIONS: Univariate analysis and multivariate Cox proportional hazard regression analysis indicated that intraoperative conversion did not significantly influence the OS and RFS rate of these patients. Our results demonstrated that the intraoperative conversion did not affect the long-term survival of patients underwent MIE for ESCC.
引用
- Liu XH, Hu Y, Li KK, et al. Intraoperative conversion does not affect the oncological outcomes of minimally invasive esophagectomy for treatment of esophageal cancer. Surg Endosc. 2018. PMID: 29766306. doi:10.1007/s00464-018-6202-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。